Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q3 EPS of ($7.88), $6.38 worse than the analyst estimate of ($1.50).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.